Related by context. All words. (Click for frequent words.) 70 dyskinesia 69 myoclonus 67 akinesia 66 gastrointestinal motility 66 involuntary movements 66 L dopa 65 levodopa therapy 64 extrapyramidal symptoms 64 levodopa induced 64 cerebral ischemia 64 primidone 64 hyperprolactinemia 64 involuntary muscle contractions 63 generalized seizures 63 tremors rigidity 63 hyperalgesia 63 muscle spasticity 63 opioid induced 63 chorea 63 tremor slowness 62 tremor rigidity 62 allopregnanolone 62 extrapyramidal 62 postural instability 62 dopamine agonist 62 tardive dyskinesia TD 62 induce orthostatic hypotension 62 parkinsonian 62 bradykinesia 62 daytime drowsiness 62 pyridostigmine 61 conventional DMARDs 61 generalized tonic clonic seizures 61 hyperexcitability 61 nausea constipation 61 QT intervals 61 motor neuropathy 61 oxcarbazepine 61 locomotor activity 61 L DOPA 61 Restless Legs Syndrome RLS 61 growth hormone secretion 61 adrenal suppression 61 NMDA antagonist 61 muscle rigidity 61 overactive bladder symptoms 61 orthostatic hypotension 61 Levodopa 61 Overactive bladder 61 autoantibody levels 61 myoclonic 61 torsade de pointes 61 ictal 61 potentiation 61 Neuropathic pain 61 levodopa 61 IL 1ß 61 flecainide 61 paresthesia 60 cortical excitability 60 progressive neurodegenerative disorder 60 muscarinic receptors 60 tonic clonic seizures 60 Essential tremor 60 QTc intervals 60 clomipramine 60 prolactin levels 60 MAO inhibitors 60 tau pathology 60 VIIBRYD 60 nortriptyline Pamelor 60 hyperammonemia 60 bladder contractions 60 denervation 60 PAOD 60 circadian rhythm sleep 60 cognitive deficits 60 prolonged QT interval 60 nocturnal enuresis 60 phonic tics 60 neurohormones 60 mu opioid receptor antagonist 60 monoamine 60 cortical activation 60 TEAEs 60 insomnia somnolence 60 frequent awakenings 60 neurological disorder characterized 60 anxiolytic 60 neuroleptics 60 drowsiness dizziness 60 tolterodine 60 claudication 60 lichen planus 60 allodynia 60 anticholinergic agents 60 parkinsonism 59 inotropes 59 fluoxetine Prozac 59 sotalol 59 airflow limitation 59 extrapyramidal symptoms EPS 59 parkinsonian symptoms 59 HPA axis 59 idiopathic Parkinson disease 59 generalized epilepsy 59 diabetic gastroparesis 59 ropinirole 59 entacapone 59 neurologic symptoms 59 excessive sleepiness 59 coadministration 59 dopaminergic therapy 59 neuropsychiatric symptoms 59 extracellular dopamine 59 urinary leakage 59 serotonin receptor 59 serotonin reuptake 59 cardiac fibrosis 59 hypoxemia 59 vasodilatation 59 drowsiness nausea 59 neurotransmitters serotonin 59 overactivity 59 impaired cognition 59 mania hypomania 59 dysmenorrhoea 59 intravitreal injections 59 pressure natriuresis 59 proliferative diabetic retinopathy 59 cortisol secretion 59 dosing frequency 59 blepharospasm 59 EFFEXOR XR 59 GI motility 59 hemiparesis 59 Akathisia 59 intermittent hypoxia 59 safinamide 59 postoperative delirium 59 thrombocytopenic patients 59 antiandrogen 59 hypersomnia 59 intraocular pressure IOP 59 Parkinsonian 59 polyuria 58 involuntary muscle spasms 58 bone marrow suppression 58 hypomanic episodes 58 lordosis 58 postural stability 58 desipramine 58 atrial tachyarrhythmias 58 baroreflex 58 Enlarged prostate 58 anti androgen 58 constipating effects 58 myotonia 58 RLS symptoms 58 nociceptive pain 58 pharmacologic approaches 58 pharmacokinetic interactions 58 glitazone class 58 overactivation 58 nicotinic acid 58 nerve degeneration 58 paroxysmal AF 58 Ménière disease 58 venlafaxine Effexor 58 headache nasopharyngitis 58 sedating antihistamine 58 somnolence dizziness 58 fluid overload 58 glutamate signaling 58 analgesic medications 58 cardiac conduction 58 parasomnias 58 cytopenias 58 prolactin elevation 58 Parkinson disease PD 58 Prostatitis 58 gait disturbances 58 mu opioid 58 sulfasalazine 58 dopamine antagonists 58 rCBF 58 analgesic effects 58 antiandrogens 58 nocturnal hypoglycaemia 58 painful menstruation 58 QT interval prolongation 58 Angioedema 58 QTc interval 58 hyperreflexia 58 cholinergic 58 AGILECT R 58 Peripheral edema 58 nystagmus 58 hypothalamic pituitary 58 microglial activation 58 hepatotoxicity 58 HER2 overexpression 58 Urge incontinence 58 LHRH agonists 58 hyperactivation 58 hematologic toxicity 58 MAO inhibitor 58 leukocyte counts 58 tremors stiffness slowness 58 QT interval 58 omeprazole Prilosec 58 photosensitivity 58 jerky involuntary 58 glucocorticoid 58 aminotransferases 58 gastro esophageal reflux 58 convulsive seizures 58 akathisia 58 emotional lability 58 renal fibrosis 58 pharmacologic 58 JAK2 enzyme 58 INVEGA R 58 TGF beta signaling 58 urate lowering 58 neurologic dysfunction 58 reflux symptoms 57 extrapyramidal disorder 57 dopaminergic 57 zopiclone 57 adrenal insufficiency 57 activating dopamine receptors 57 BANZEL 57 hyperhydrosis 57 p# activation 57 mitochondrial toxicity 57 estrogen deficiency 57 overt nephropathy 57 hematological toxicity 57 Transcranial magnetic stimulation 57 serum cortisol 57 NUCYNTA R 57 postoperative AF 57 serotonin reuptake inhibitors 57 Aortic stenosis 57 bladder dysfunction 57 transient insomnia 57 Drowsiness 57 anticonvulsants 57 alpha interferons 57 ULTRAM ER 57 neuronal dysfunction 57 neuro protective 57 tic disorder 57 5 HT1A 57 Nocturia 57 Ventricular Tachycardia 57 β blockers 57 musculoskeletal pain 57 anterior temporal 57 Tasimelteon 57 neuropathic 57 Hypotension 57 Nardil 57 neurocognitive function 57 mecamylamine 57 neurologic disorders 57 somnolence sleepiness 57 left ventricular diastolic 57 Carpal tunnel 57 Bruxism 57 5 HT2A receptor 57 neurologic deficits 57 esotropia 57 pentoxifylline 57 corrected QT interval 57 leukotriene receptor antagonists 57 torsades de pointes 57 nadolol 57 Sinemet 57 neuronal plasticity 57 apneic episodes 57 Withdrawal symptoms 57 experimentally induced 57 neuroleptic 57 apomorphine 57 paroxetine Paxil 57 primary Restless Legs 57 CNS depressant 57 abrupt discontinuation 57 nasopharyngitis headache 57 pilocarpine 57 selegiline 57 epilepsies 57 galanin 57 metabolic disturbances 57 pulmonary exacerbations 57 ocular adverse 57 lightheadedness dizziness 57 nephrotoxicity 57 H2 antagonists 57 tonic clonic 57 Parkinson Disease PD 57 melatonin receptors 57 rhinorrhea 57 Oral mucositis 57 INVEGA ® 57 beta adrenergic receptors 57 acetabular dysplasia 57 hepatic glucose production 57 constipation nausea 57 paresthesias 57 nonvertebral fracture 57 CYP #A# 57 MIRAPEX 57 hypoglycemic episodes 57 intravenous cyclophosphamide 57 propranolol Inderal 57 dermatologic reactions 57 Chronic insomnia 57 DFMO 57 baclofen 57 hyperphenylalaninemia HPA due 57 monogenic 57 anterior uveitis 57 syndrome OSAS 57 cholinergic tone 57 neuroprotective agent 57 APTIVUS r 57 pharmacologically 57 neurotransmitter GABA 57 acute decompensation 57 disc degeneration 57 Peripheral neuropathy 57 psychostimulants 57 jerking movements 57 motor neuron degeneration 57 uric acid lowering 57 urticaria hives 57 Meniere disease 57 antiarrhythmic 57 serotonergic 57 QTc prolongation 57 atopic eczema 57 hepatotoxic 57 Zoloft sertraline 57 Selective serotonin reuptake inhibitors 56 osteoarthritis rheumatoid arthritis 56 ischaemia 56 primary axillary hyperhidrosis 56 coagulopathy 56 cough wheezing 56 sustained muscle contractions 56 allergic dermatitis 56 secondary hyperparathyroidism 56 vasomotor symptoms 56 seborrheic dermatitis 56 phenelzine 56 Premature ejaculation 56 hepatocellular 56 photic 56 Obstructive sleep apnea OSA 56 hirsutism 56 desvenlafaxine succinate 56 thrombocytosis 56 premenstrual syndrome PMS 56 generalized anxiety disorder GAD 56 tricyclics 56 cardiotoxic 56 adjunctive ABILIFY 56 constipation predominant IBS 56 adrenocorticotropic hormone 56 Disulfiram 56 da mage 56 LATUDA 56 psychomotor agitation 56 reuptake inhibitor 56 bowel dysfunction 56 androgen deprivation 56 ventricular tachycardia VT 56 vaso 56 inherited retinal degeneration 56 clinically meaningful reductions 56 excitatory 56 metabolic parameters 56 ACh 56 paricalcitol 56 pituitary hormone 56 latanoprost 56 hemiplegia 56 paroxysmal 56 elevated IOP 56 calcium homeostasis 56 daytime alertness 56 painful muscle spasms 56 depression irritability 56 carotid atherosclerosis 56 nonpharmacologic 56 triiodothyronine 56 haematologic 56 serum urate 56 Sleepiness 56 torticollis 56 neovascularisation 56 penile erection 56 noradrenergic 56 Parkinsonism 56 hypoglycaemic episodes 56 menopausal hot flushes 56 headache nausea diarrhea 56 idiopathic PD 56 daytime sleepiness 56 allergic inflammation 56 phenothiazines 56 Spinal manipulation 56 akinetic mutism 56 tricyclic antidepressant 56 levodopa carbidopa 56 antiepileptic drugs AEDs 56 haloperidol Haldol 56 hippocampal volume 56 SUSTENNA TM 56 factor TNF 56 Daytime sleepiness 56 onset seizures 56 cardiac repolarization 56 hypothalamic pituitary axis 56 dystonic 56 tapentadol ER 56 topical corticosteroid 56 mGluR5 antagonist 56 ramelteon 56 tibolone 56 tricyclic 56 IFN γ 56 electrophysiologic 56 cartilage degeneration 56 BYSTOLIC 56 Parkinsonian symptoms 56 Thrombocytopenia 56 prescribed proton pump 56 JAK STAT signaling 56 ventricular repolarization 56 MS relapses 56 vomiting constipation 56 spinal misalignment 56 microvascular complications 56 hypometabolism 56 adrenocorticotropic hormone ACTH 56 Hypocalcemia 56 ursodeoxycholic acid 56 Diabetic neuropathy 56 dopamine reuptake 56 amyloid β 56 CYT# potent vascular disrupting 56 myalgias 56 treating neuropathic pain 56 euthymic patients 56 imipramine 56 clobazam 56 BMP signaling 56 colonic motility 56 Abdominal pain 56 vasodilation 56 systemic corticosteroid 56 contractility 56 anticancer treatments 56 potassium sparing diuretics 56 hypoglycemic events 56 fibrotic disease 56 mTOR inhibitors 56 peripheral neuropathy CIPN 56 afterload 56 anticholinergic effects 56 detrusor overactivity 56 hypothalamic pituitary adrenal axis 56 BPPV 56 recurrent venous thromboembolism 56 abnormal ejaculation 56 L Dopa 56 thromboembolic disease 56 dentinal hypersensitivity 56 Desmopressin 56 extraocular 56 neovascular 56 repetitive transcranial magnetic stimulation 56 glutamate neurotransmission 56 tricyclic antidepressants 56 Obstructive sleep apnea 56 nasal obstruction 56 dysmenorrhea 56 tic severity 56 vagal 56 milrinone 56 menopausal symptom 56 artery stenosis 56 nocturnal hypoglycemia 56 Imipramine 56 #HT#A 56 airway constriction 56 tiagabine 56 dopamine signaling 56 Circadian rhythm 56 dyskinesia PD LID 56 rotigotine 56 exendin 4 56 intermittent claudication 56 tranylcypromine 56 menstrual pain 56 hepatic fibrosis 56 SRBD 55 ventricular tachyarrhythmias 55 sleep apnea narcolepsy 55 dysfunctional voiding 55 anovulation 55 gait disturbance 55 seborrhea 55 tremors slowness 55 VA# [002] 55 neurologic disorder 55 symptomatology 55 hypothalamic pituitary adrenal HPA 55 dopamine agonists 55 intractable hiccups 55 disorder FSAD 55 Cluster headaches 55 monoamines 55 ventricular arrhythmia 55 beta interferons 55 sertraline Zoloft 55 vertigo dizziness 55 severe hypoglycaemia 55 antidepressants SSRIs 55 daytime somnolence 55 intestinal motility 55 neuropsychiatric diseases 55 opioid analgesia 55 antidiuretic hormone 55 GABAA receptors 55 antiepileptics 55 depolarizing 55 antiarrhythmic drug 55 Lamotrigine 55 NIASPAN 55 vessel dilation 55 arousals 55 Sleep disturbances 55 pulmonary hypertension PH 55 comorbid depression 55 repolarization 55 acamprosate 55 nerve conduction velocity 55 myopathy rhabdomyolysis 55 receiving XGEVA 55 postoperative ileus 55 GH secretion 55 hypoperfusion 55 neuroleptic drugs 55 neurosteroid 55 sinus tachycardia 55 cerebral vasospasm 55 hallux limitus 55 triazolam 55 electroencephalographic 55 Enbrel Humira 55 nonarteritic anterior ischemic optic 55 nighttime urination 55 LTB4 55 postprandial glycemia 55 T2DM 55 GnRH agonist 55 electrolyte abnormalities 55 intracranial hypertension 55 tremors stiffness 55 PsA 55 epistaxis 55 antiseizure 55 Magnesium deficiency 55 adrenal function 55 Methylphenidate 55 pressor response 55 behavioral abnormalities 55 optic neuropathy NAION 55 brain neurochemistry 55 cardiac toxicity 55 enkephalins 55 painful diabetic neuropathy 55 metabolic dysfunction 55 neuropsychiatric disorder 55 transgene expression 55 phosphodiesterase inhibitors 55 antiemetics 55 alexithymia 55 chloride secretion 55 choroidal neovascularization 55 adrenal exhaustion 55 Quetiapine 55 Topiramate 55 MEVACOR 55 underarm sweating 55 Chronic ITP 55 hyperinsulinemia 55 bipolar mania trials 55 serotonin reuptake inhibitor 55 dose proportional pharmacokinetics 55 sensory disturbances 55 antimuscarinic 55 ventricular tachyarrhythmia 55 syndrome RLS 55 muscular rigidity 55 citalopram Celexa 55 variant angina 55 colorectal adenoma 55 extrapyramidal side 55 brain lesions 55 Almorexant 55 neurocognitive impairment 55 psychostimulant drugs 55 systemic toxicity 55 RLAI 55 leukoencephalopathy 55 nausea vomiting headache 55 apneic 55 Tasigna prolongs 55 recurrent VTE 55 K ras mutations 55 seminomas 55 exotropia 55 gastrointestinal disturbances 55 inverse agonists 55 hyper excitability 55 QT prolongation 55 pramipexole Mirapex 55 EXJADE 55 cognitive dysfunction 55 recurrent seizures 55 papilledema 55 myeloproliferative diseases 55 oncogenic transformation 55 idraparinux 55 6 OHDA 55 androgen depletion 55 NMDA receptor antagonist 55 dust mite allergies 55 ALISTA 55 metabolic abnormalities 55 gastro oesophageal reflux 55 involuntary tics 55 gabapentin Neurontin 55 pramipexole 55 weekly subcutaneous injections 55 glycosylated hemoglobin HbA1c 55 ICD shocks 55 clinically meaningful improvements 55 metabolic acidosis 55 dryness irritation 55 serum HBV DNA 55 GPi 55 platelet activation 55 INVEGA ™ 55 nociceptive 55 syncope fainting 55 intact parathyroid hormone 55 atrophic gastritis 55 pseudotumor cerebri 55 Ritalin methylphenidate 55 neurological degeneration 55 myoclonic seizures 55 vWD 55 GABA receptor 55 telogen effluvium 55 H2 blockers 55 somatic complaints 55 Decitabine 55 amenorrhea 55 endoplasmic reticulum stress 55 PMS symptoms 55 hypogonadotropic hypogonadism 55 hallux valgus 55 MIRAPEX ER 55 Tardive Dyskinesia 55 anakinra 55 urinary retention 55 cerebrovascular events 55 serotonin neurotransmission 55 carbidopa levodopa 55 headache dizziness fatigue 55 tardive dyskinesia 55 Ropinirole 55 somatostatin analogs 55 symptomatic paroxysmal AF 55 monoamine oxidase inhibitor 55 electro acupuncture 55 Erythropoietic therapies may 55 MELAS 55 LHRH antagonists 55 ANCA associated 55 hypercalciuria 55 kyphosis 55 Hydroxyurea 55 RISPERDAL ® 55 NUCYNTA ™ 55 vasogenic edema 55 adrenergic 55 ileus 55 sedative hypnotics 55 thiazide diuretic 55 antiplatelet medications 55 timolol 55 Rotigotine 55 obstructive sleep 55 inattention hyperactivity 55 nucleoside analogues 55 Parkinson disease neurodegenerative disorder 55 bothersome symptom 55 autonomic dysfunction 55 basal cell nevus syndrome 55 transaminase elevations 55 Chronic pancreatitis 55 HbF 55 deep venous thromboses 55 calcium excretion 55 CorVue ™ 55 inflammatory cytokine 55 Torsades de Pointes 55 ALT flares 55 serum phosphate 55 guanfacine 55 hypopneas 55 behavioral disinhibition 55 hyperemesis 55 osteosarcomas 55 desmopressin 55 trospium 55 rearfoot 55 corticosteroid therapy 55 antidepressive 55 juvenile idiopathic arthritis 55 oncomodulin 55 hiatal hernias 55 OAB symptoms 55 experimental autoimmune encephalomyelitis 55 monozygotic twin 55 Barbiturates 54 cardioprotection 54 agitation hallucinations 54 conventional antipsychotics 54 CIPN 54 retrograde ejaculation 54 inhaled corticosteroids ICS 54 AZILECT R 54 Zollinger Ellison Syndrome 54 neuroprotective effects 54 SGPT 54 topical corticosteroids 54 pharmacologic treatments 54 vascular endothelial dysfunction 54 PHPT 54 zolmitriptan 54 molindone 54 urine leakage 54 inhibitory neurotransmitters 54 prostaglandin E1 54 vasovagal syncope 54 dizziness insomnia 54 salicylates 54 GABA aminotransferase 54 airway narrowing 54 hypovolemia 54 Natalizumab 54 spasticity 54 muscle twitches 54 sleep apneas 54 relapsing remitting 54 endocannabinoid signaling 54 NMDA receptor antagonists 54 tumor regressions 54 subclinical inflammation 54 thunderclap headache 54 vaso occlusive crisis 54 anticholinergics 54 syndrome gastroesophageal reflux 54 fatty acid oxidation 54 electroacupuncture 54 Prostacyclin 54 muscle dysmorphia 54 neurocognitive deficits 54 headache abdominal pain 54 neurological dysfunction 54 loop diuretics 54 disk herniation 54 TMP SMX 54 nausea photophobia 54 selective modulator 54 jerky movements 54 #ME# 54 antidiabetic medications 54 saccades 54 chelation DMSA 54 apneas 54 heart palpitations dizziness 54 Atopic dermatitis 54 neuroinflammation 54 Acid reflux 54 serotonin receptors 54 ADHD symptoms 54 ventricular remodeling 54 depressive relapse 54 venlafaxine XR 54 vascular permeability 54 metabolic abnormality 54 2A receptor agonist 54 quetiapine Seroquel 54 Carbidopa 54 hyperarousal 54 antidepressant efficacy 54 mood swings irritability 54 VMAT2 54 CYP#D# inhibitor 54 TOVIAZ 54 GH deficiency 54 efalizumab 54 tryptophan depletion 54 benign positional vertigo 54 H2 receptor antagonists 54 blood Phe levels 54 hypercalcemia 54 opiate agonist 54 isoproterenol 54 thyrotropin 54 prodrome 54 Heavy menstrual bleeding 54 typical antipsychotics 54 apnea hypopnea 54 ischemia induced 54 hyperkalemia 54 probiotic supplementation 54 danazol 54 vasomotor 54 adrenal hormones 54 prefrontal cortical 54 neutropaenia 54 hypocalcemia 54 moderate renal impairment 54 juvenile idiopathic arthritis JIA 54 hypotensive 54 sodium valproate 54 glutamate receptors 54 acute mania 54 ovarian hormones 54 tics involuntary 54 overt hypothyroidism 54 primary generalized tonic 54 luteal phase 54 post thrombotic syndrome 54 variceal bleeding 54 spontaneous erections 54 airway reactivity 54 hormone secretion 54 Prozac fluoxetine 54 dysplasias 54 psychosocial variables 54 endometrial hyperplasia 54 Pathological gambling 54 nonhematologic adverse reactions 54 Fluid retention 54 postural sway 54 chromosomal rearrangement 54 bone resorption 54 Symadex 54 Intussusception 54 #beta HSD1 54 headache blurred vision 54 SNRI 54 thrombocytopenia neutropenia 54 persistent pulmonary hypertension 54 methylphenidate Ritalin 54 biphosphonates 54 bexarotene 54 repetitive stereotyped 54 cannabinor 54 hyperresponsiveness 54 generalized dystonia 54 headaches stomach aches 54 Mellaril 54 nonsteroidal 54 hyperglycaemia 54 opioid receptor antagonist 54 diplopia 54 polydipsia 54 obstructive sleep apnea hypopnea 54 thromboembolic events 54 ancrod 54 CYP#A# inhibitors 54 prolonged QT intervals 54 levetiracetam Keppra 54 aspartate aminotransferase AST 54 Chronic pelvic 54 disulfiram 54 dysarthria 54 anticholinergic drugs 54 delayed gastric emptying 54 hepatic encephalopathy HE 54 motoneurons 54 inherited neurological disorder 54 treat benign prostatic 54 Chronic constipation 54 flow mediated dilation 54 acetylcholine receptor 54 lipid parameters 54 receptor inhibitor 54 Sjögren syndrome 54 prednisone prednisolone 54 microvascular disease 54 Calorie restriction 54 antipsychotic efficacy 54 hepatic toxicity 54 prescribed diuretics 54 optic neuropathy 54 psychomotor retardation 54 sensory neuropathy 54 endotoxemia 54 headache diarrhea nausea 54 nonmelanoma skin cancers 54 diarrhea constipation 54 symptom severity 54 thyroid hormone levels 54 Juvenile Idiopathic Arthritis 54 parietal cortices 54 nasal stuffiness 54 serum phosphate levels 54 muscle twitching 54 tumor necrosis 54 fatty infiltration 54 vagal nerve 54 urinary excretion 54 ADPKD 54 vascular dysfunction 54 serum calcium levels 54 neuromuscular blockade 54 5 alpha reductase 54 intracranial hemorrhage ICH 54 either acutely decompensated 54 metaplasia 54 neurosensory 54 ziconotide 54 somnolence sedation 54 proliferative retinopathy 54 indomethacin 54 γ secretase 54 stimulant ADHD 54 GABAergic 54 corticosteroid dose 54 receptor subtypes 54 seropositive patients 54 subclinical hypothyroidism 54 urinary symptoms 54 involuntary twitching 54 steroid dexamethasone 54 neurohormonal 54 ovulatory cycles 54 poststroke 54 gastric distention 54 symptomatic VTE 54 modafinil Provigil 54 Eltrombopag 54 hyperactivity inattention 54 ionic currents 54 IOP lowering 54 SIADH 54 nicotinic acetylcholine receptors 54 disordered breathing 54 fatal anaphylactic 54 pupillary 54 Gabapentin enacarbil 54 arthralgias 54 citalopram 54 headache nausea dizziness 54 Tardive dyskinesia 54 menstrual bleeding 54 GlaxoSmithKline Requip 54 C1 INH deficiency 54 virologic breakthrough 54 hypercholesterolaemia 54 amisulpride 54 refractory gout 54 bezafibrate 54 RoACTEMRA 54 incontinence episodes 54 pronation 54 act synergistically 54 Spasticity 54 lenalidomide dexamethasone 54 urate lowering therapy 54 aromatase inhibitor therapy 54 temporomandibular disorders 54 axonal damage 54 dysrhythmias 54 paroxysmal supraventricular tachycardia